newsfilter
← Latest News
ACCESS Newswire·

Protagenic Therapeutics Announces Date of Annual Shareholder Meeting

NEW YORK, NY / ACCESSWIRE / October 13, 2023 / Protagenic Therapeutics, Inc. a biopharmaceutical company focused on developing therapies to treat stress-related neurologic disorders, today announced its FY